Autonomic nerve fiber function and bone mineral density in individuals with type 1 diabetes: A cross-sectional study

Diabetes Research and Clinical Practice

Volumn 84, Issue 3, 2009, Pages 252-258

  Maser, Raelene E ^a,b   Stabley, John N ^a   Lenhard, M James ^b   Provost Craig, Michelle A ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

Autonomic nerve fiber function; Bone mineral density; Diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN DERIVATIVE; NORADRENALIN;

ADULT; ARTICLE; AUTONOMIC NERVE; AUTONOMIC NERVOUS SYSTEM; BLOOD SAMPLING; BODY MASS; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; FEMALE; FUNCTIONAL ASSESSMENT; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NERVE FIBER; NORADRENALIN BLOOD LEVEL; PHYSICAL ACTIVITY;

ABSORPTIOMETRY, PHOTON; ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BONE AND BONES; BONE DENSITY; CALCIFEDIOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NERVE FIBERS; NOREPINEPHRINE; PATIENT SELECTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 65149092249     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.02.012     Document Type: Article

References (45)

1. Reid I.R., Lucas J., Wattie D., Horne A., Bolland M., Gamble G.D., et al. Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial. J. Clin. Endocrinol. Metab. 90 (2005) 5212-5216
2. Moore R.E., Smith 2nd C.K., Bailey C.S., Voelkel E.F., and Tashjian Jr. A.H. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner. 23 (1993) 301-315
3. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111 (2002) 305-317
4. Kellenberger S., Muller K., Richener H., and Bilbe G. Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors. Bone 22 (1998) 471-478
5. Cherruau M., Facchinetti P., Baroukh B., and Saffar J.L. Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone 25 (1999) 545-551
6. Pasco J.A., Henry M.J., Sanders K.M., Kotowicz M.A., Seeman E., Nicholson G.C., et al. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J. Bone Miner. Res. 19 (2004) 19-24
7. Schlienger R.G., Kraenzlin M.E., Jick S.S., and Meier C.R. Use of beta-blockers and risk of fractures. JAMA 292 (2004) 1326-1332
8. Tuominen J.T., Impivaara O., Puukka P., and Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22 (1999) 1196-1200
9. Forst T., Pfutzner A., Kann P., Schehler B., Lobmann R., Schafer H., et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet. Med. 12 (1995) 874-879
10. Hui S.L., Epstein S., and Johnston Jr. C.C. A prospective study of bone mass in patients with type I diabetes. J. Clin. Endocrinol. Metab. 60 (1985) 74-80
11. Miazgowski T., and Czekalski S. A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos. Int. 8 (1998) 399-403
12. Mathiassen B., Nielsen S., Johansen J.S., Hartwell D., Ditzel J., Rodbro P., et al. Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J. Diabet. Complications 4 (1990) 145-149
13. Nicodemus K.K., and Folsom A.R. Iowa Women's Health Study, Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24 (2001) 1192-1197
14. Forsen L., Meyer H.E., Midthjell K., and Edna T.H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42 (1999) 920-925
15. Schumer M., Burton G., Burton C., Crum D., and Pfeifer M.A. The Diabetes Control and Complications Trial Study Group, Diabetic autonomic neuropathy-part I. Autonomic nervous system data analysis by a computerized central unit in a multicenter trial. Am. J. Med. 85 (1988) 137-143
16. Pfeifer M.A., Cook D., Brodsky J., Tice D., Reenan A., Swedine S., et al. Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 31 (1982) 339-345
17. Schumer M.P., Joyner S.A., and Pfeifer M.A. Cardiovascular autonomic neuropathy testing in patients with diabetes. Diabetes Spectr. 11 (1998) 227-231
18. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93 (1996) 1043-1065
19. Rimoldi O., Pierini S., Ferrari A., Cerutti S., Pagani M., and Malliani A. Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs. Am. J. Physiol. 258 (1990) H967-H976
20. Malliani A., Pagani M., Lombardi F., and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84 (1991) 482-492
21. Esler M., Jennings G., Korner P., Willett I., Dudley F., Hasking G., et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11 (1988) 3-20
22. Pierroz D.D., Bouxsein M.L., Rizzoli R., and Ferrari S.L. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Bone 39 (2006) 260-267
23. Minkowitz B., Boskey A.L., Lane J.M., Pearlman H.S., and Vigorita V.J. Effects of propranolol on bone metabolism in the rat. J. Orthop. Res. 9 (1991) 869-875
24. Takeuchi T., Tsuboi T., Arai M., and Togari A. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem. Pharmacol. 61 (2001) 579-586
25. Rejnmark L., Vestergaard P., and Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J. Hypertens. 24 (2006) 581-589
26. Rejnmark L., Vestergaard P., Kassem M., Christoffersen B.R., Kolthoff N., Brixen K., et al. Fracture risk in perimenopausal women treated with beta-blockers. Calcif. Tissue Int. 75 (2004) 365-372
27. Kayath M.J., Dib S.A., and Vieira J.G. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J. Diabetes Complications 8 (1994) 97-104
28. Munoz-Torres M., Jodar E., Escobar-Jimenez F., Lopez-Ibarra P.J., and Luna J.D. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif. Tissue Int. 58 (1996) 316-319
29. Rix M., Andreassen H., and Eskildsen P. Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 22 (1999) 827-831
30. Strotmeyer E.S., Cauley J.A., Orchard T.J., Steenkiste A.R., and Dorman J.S. Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 29 (2006) 306-311
31. Strotmeyer E.S., Cauley J.A., Schwartz A.V., de Rekeneire N., Resnick H.E., Zmuda J.M., et al. Reduced peripheral nerve function is related to lower hip BMD and calcaneal QUS in older white and black adults: the Health, Aging, and Body Composition Study. J. Bone Miner. Res. 21 (2006) 1803-1810
32. Kayath M.J., Tavares E.F., Dib S.A., and Vieira J.G. Prospective bone mineral density evaluation in patients with insulin-dependent diabetes mellitus. J. Diabetes Complications 12 (1998) 133-139
33. Levin M.E., Boisseau V.C., and Avioli L.V. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N. Engl. J. Med. 294 (1976) 241-245
34. Hadjidakis D.J., Raptis A.E., Sfakianakis M., Mylonakis A., and Raptis S.A. Bone mineral density of both genders in type 1 diabetes according to bone composition. J. Diabetes Complications 20 (2006) 302-307
35. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos. Int. 18 (2007) 427-444
36. van Beresteijn E.C., van Laarhoven J.P., and Smals A.G. Body weight and/or endogenous estradiol as determinants of cortical bone mass and bone loss in healthy early postmenopausal women. Acta Endocrinol. (Copenh.) 127 (1992) 226-230
37. Miyabara Y., Onoe Y., Harada A., Kuroda T., Sasaki S., and Ohta H. Effect of physical activity and nutrition on bone mineral density in young Japanese women. J. Bone Miner. Metab. 25 (2007) 414-418
38. Bridges M.J., Moochhala S.H., Barbour J., and Kelly C.A. Influence of diabetes on peripheral bone mineral density in men: a controlled study. Acta Diabetol. 42 (2005) 82-86
39. Thrailkill K.M., Lumpkin Jr. C.K., Bunn R.C., Kemp S.F., and Fowlkes J.L. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E735-E745
40. Heap J., Murray M.A., Miller S.C., Jalili T., and Moyer-Mileur L.J. Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J. Pediatr. 144 (2004) 56-62
41. Gunczler P., Lanes R., Paz-Martinez V., Martins R., Esaa S., Colmenares V., et al. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J. Pediatr. Endocrinol. Metab. 11 (1998) 413-419
42. Uusi-Rasi K., Sievanen H., Vuori I., Pasanen M., Heinonen A., and Oja P. Associations of physical activity and calcium intake with bone mass and size in healthy women at different ages. J. Bone Miner. Res. 13 (1998) 133-142
43. Espallargues M., Sampietro-Colom L., Estrada M.D., Sola M., del Rio L., Setoain J., et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos. Int. 12 (2001) 811-822
44. Winters K.M., and Snow C.M. Detraining reverses positive effects of exercise on the musculoskeletal system in premenopausal women. J. Bone Miner. Res. 15 (2000) 2495-2503
45. Kriska A.M., LaPorte R.E., Patrick S.L., Kuller L.H., and Orchard T.J. The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: The Epidemiology of Diabetes Complications Study-VII. J. Clin. Epidemiol. 44 (1991) 1207-1214